Shilpa Medicare moves up on getting GMP Certification from AGES, Austria for Telangana facility
Shilpa Medicare is currently trading at Rs. 1,086.10, up by 3.30 points or 0.32% from its previous closing of Rs. 1020.35 on the BSE.
The scrip opened at Rs. 1045.00 and has touched a high and low of Rs. 1047.80 and Rs. 1018.55 respectively. So far 17090 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1095.65 on 01-Oct-2026 and a 52 week low of Rs. 260.00 on 27-Jan-2026.
Last one week high and low of the scrip stood at Rs. 1,086.10 and Rs. 993.65 respectively. The current market cap of the company is Rs. 20239.78 crore.
The promoters holding in the company stood at 40.13%, while Institutions and Non-Institutions held 20.37% and 39.49% respectively.
Shilpa Medicare has received GMP Certification from AGES, Austria for its Unit 4, Jadcherla, Telangana, India, following a successful inspection. AGES, Austria had conducted inspection at the said facility from July 27, 2026 to July 30, 2026.
This Unit of Shilpa Medicare is engaged in the manufacturing, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in Europe and rest of the world markets.
